In the last trading session, 0.23 million shares of the AEON Biopharma Inc (AMEX:AEON) were traded, and its beta was 0.50. Most recently the company’s share price was $0.53, and it changed around -$0.02 or -2.73% from the last close, which brings the market valuation of the company to $6.04M. AEON currently trades at a discount to its 52-week high of $269.28, offering almost -50707.55% off that amount. The share price’s 52-week low was $0.38, which indicates that the current value has risen by an impressive 28.3% since then.

AEON Biopharma Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended AEON as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.

AEON Biopharma Inc (AMEX:AEON) trade information

Instantly AEON has showed a red trend with a performance of -2.73% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.5550 on recent trading dayincreased the stock’s daily price by 4.5%. The company’s shares are currently down -98.63% year-to-date, but still up 6.80% over the last five days. On the other hand, AEON Biopharma Inc (AMEX:AEON) is 16.09% up in the 30-day period.

AEON Dividends

AEON Biopharma Inc’s next quarterly earnings report is expected to be released in June.

Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Mar 31, 2025 . The former held 6.28 shares worth $3351.0, making up 0.06% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund held roughly 5.76 shares worth around $3077.0, which represents about 0.05% of the total shares outstanding.